Company: APAD
Filing Date: 2025-07-09
Form Type: S-1/A
Source: 0001213900-25-062242
Chunk: 249

Company: AParadise Acquisition Corp.
Filing Date: 2025-07-09
Form: S-1/A
Chunk 249
---
 advisory and asset management services, under type 4 (Advising on Securities) and Type 9 (Asset Management) licenses. Mr.Ng is also a Managing Partner of the NM Strategic Focus Fund I and II, which are both private equity funds with a focus on making direct investments and providing growth capital to companies in the areas of technology, fintech, health care and consumer services in Asia Pacific and the Greater China region. Private 145 Equity Investee companies include the likes of Lufax (“LU US EQUITY”), Ping An Health and Technology (“1833 HK”) and Animoca Brands. He previously served as Co -ChiefExecutive Officer of Black Spade Acquisition Co, which consummated a business combination with VinFast Auto Pte. Ltd. in August 2023. From 2006 to 2013, Mr.Ng worked at J.P. Morgan where he was the Chairman and Head of Equity Capital & Derivatives Markets for the whole Asia Pacific region (including Japan and Australia), responsible for raising capital for both public and private companies via initial public offerings, equity -linkedofferings and pre -IPOtransactions. Prior to J.P. Morgan, Mr.Ng served as the Managing Director and Head of Greater China Equity Capital Markets at Merrill Lynch and worked there from 1995 to 2006 in London and Hong Kong. Over his professional career, Mr.Ng is one of the most senior ECM bankers in the Asia Pacific Region, having completed a significant number of IPOs, equity and equity -linkedtransactions. His experience includes more than 100 IPOs, pre -IPOsand equity linked transactions for Asia Pacific companies, raising over $100billion on the major stock exchanges globally, including Hong Kong, NYSE, NASDAQ, London and Singapore. He completed the Agricultural Bank of China’s $22billion dual listed Hong Kong and Shanghai IPO in 2010, which was the largest IPO globally ever at the time. Mr.Ng also served as a director of the boards of both J.P Morgan Securities (Asia Pacific) Limited and J.P. Morgan Broking (Hong Kong) Limited. In addition, he also previously served as a Hong Kong SFC Responsible Officer as well as a Hong Kong Monetary Authority Executive Officer. Mr.Ng has a bachelor’s degree in medical sciences from the University of Nottingham Medical School, United Kingdom. Past performance of our management team, our advisors or their affiliates is not a guarantee either (i) of success with respect to any business combination we may